National Biodefense Science Board Public Meeting, 73351 [2023-23532]

Download as PDF Federal Register / Vol. 88, No. 205 / Wednesday, October 25, 2023 / Notices Based on a current evaluation of the information collection, we have adjusted the burden estimate. Our estimated burden for the information collection reflects an overall increase of 2,687 hours and a corresponding increase of 2,687 responses. CDER has instituted electronic certificates of pharmaceutical product (eCPP) to streamline the application process and reduce the time from receipt to issuance of export certificates. The increase in CDER export application requests is attributable to the implementation of the eCPP and an increase in drug exports. The increase is offset by a decrease in CVM and CBER export applications attributable to consequences of the pandemic. Dated: October 20, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–23561 Filed 10–24–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Biodefense Science Board Public Meeting Language translation and Communication Access Real-Time Translation will be provided. Representatives from industry, academia, health professions, health care consumer organizations, nonfederal government agencies, or community-based organizations may request up to seven minutes to speak directly to the Board. Requests to speak to the Board will be approved in consultation with the Board Chair and based on time available during the meeting. Requests to speak to the NBSB during the public meeting must be sent to NBSB@hhs.gov by close of business on November 23, 2023. Please provide the full name, credentials, official position(s), and relevant affiliations for the speaker and a brief description of the intended topic. Presentations that contain material with a commercial bias, advertising, marketing, or solicitations will not be allowed. A meeting summary will be available on the NBSB website post-meeting. FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue; NBSB Designated Federal Official, (202) 480– 7226; NBSB@HHS.GOV. Dawn O’Connell, Assistant Secretary for Preparedness and Response. Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: [FR Doc. 2023–23532 Filed 10–24–23; 8:45 am] BILLING CODE 4150–37–P The National Biodefense Science Board (NBSB) will publicly meet using an online format on Thursday, November 30, 2023 (12:30 to 4:00 p.m. ET). Notice of the meeting is required under section 10(a)(2) of the Federal Advisory Committee Act (FACA). The NBSB provides expert advice and guidance to the U.S. Department of Health and Human Services (HHS) regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters related to disaster preparedness and response. The Administration for Strategic Preparedness and Response (ASPR) manages and convenes the NBSB on behalf the Secretary of HHS. The NBSB will discuss and vote on two sets of recommendations related to COVID–19 pandemic lessons, Project NextGen vaccine and therapeutic products, and disaster preparedness training. Procedures for Public Participation: The public and expert stakeholders are invited to observe the meeting. Preregistration (Zoom) is required. Anyone may submit questions and comments to the NBSB by email (NBSB@hhs.gov) before the meeting. American Sign lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:01 Oct 24, 2023 Jkt 262001 DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [OMB Control Number 1615–0092] Agency Information Collection Activities; Revision of a Currently Approved Collection: E-Verify Program U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: 30-Day notice. AGENCY: The Department of Homeland Security (DHS), U.S. Citizenship and Immigration Services (USCIS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The purpose of this notice is to allow an additional 30 days for public comments. DATES: Comments are encouraged and will be accepted until November 24, 2023. SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 73351 Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, must be submitted via the Federal eRulemaking Portal website at https:// www.regulations.gov under e-Docket ID number USCIS–2007–0023. All submissions received must include the OMB Control Number 1615–0092 in the body of the letter, the agency name and Docket ID USCIS–2007–0023. FOR FURTHER INFORMATION CONTACT: USCIS, Office of Policy and Strategy, Regulatory Coordination Division, Samantha Deshommes, Chief, telephone number (240) 721–3000 (This is not a toll-free number; comments are not accepted via telephone message.). Please note contact information provided here is solely for questions regarding this notice. It is not for individual case status inquiries. Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS website at https://www.uscis.gov, or call the USCIS Contact Center at 800–375–5283 (TTY 800–767–1833). SUPPLEMENTARY INFORMATION: ADDRESSES: Comments The information collection notice was previously published in the Federal Register on June 29, 2023, at 88 FR 42091, allowing for a 60-day public comment period. USCIS received two comments in connection with the 60day notice. You may access the information collection instrument with instructions, or additional information by visiting the Federal eRulemaking Portal site at: https://www.regulations.gov and enter USCIS–2007–0023 in the search box. The comments submitted to USCIS via this method are visible to the Office of Management and Budget and comply with the requirements of 5 CFR 1320.12(c). All submissions will be posted, without change, to the Federal eRulemaking Portal at https:// www.regulations.gov, and will include any personal information you provide. Therefore, submitting this information makes it public. You may wish to consider limiting the amount of personal information that you provide in any voluntary submission you make to DHS. DHS may withhold information provided in comments from public viewing that it determines may impact the privacy of an individual or is offensive. For additional information, please read the Privacy Act notice that is available via the link in the footer of https://www.regulations.gov. E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 88, Number 205 (Wednesday, October 25, 2023)]
[Notices]
[Page 73351]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Biodefense Science Board Public Meeting

AGENCY: Administration for Strategic Preparedness and Response (ASPR), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Biodefense Science Board (NBSB) will publicly 
meet using an online format on Thursday, November 30, 2023 (12:30 to 
4:00 p.m. ET). Notice of the meeting is required under section 10(a)(2) 
of the Federal Advisory Committee Act (FACA). The NBSB provides expert 
advice and guidance to the U.S. Department of Health and Human Services 
(HHS) regarding current and future chemical, biological, radiological, 
and nuclear threats, as well as other matters related to disaster 
preparedness and response. The Administration for Strategic 
Preparedness and Response (ASPR) manages and convenes the NBSB on 
behalf the Secretary of HHS. The NBSB will discuss and vote on two sets 
of recommendations related to COVID-19 pandemic lessons, Project 
NextGen vaccine and therapeutic products, and disaster preparedness 
training.
    Procedures for Public Participation: The public and expert 
stakeholders are invited to observe the meeting. Pre-registration 
(Zoom) is required. Anyone may submit questions and comments to the 
NBSB by email ([email protected]) before the meeting. American Sign Language 
translation and Communication Access Real-Time Translation will be 
provided.
    Representatives from industry, academia, health professions, health 
care consumer organizations, non-federal government agencies, or 
community-based organizations may request up to seven minutes to speak 
directly to the Board. Requests to speak to the Board will be approved 
in consultation with the Board Chair and based on time available during 
the meeting. Requests to speak to the NBSB during the public meeting 
must be sent to [email protected] by close of business on November 23, 2023. 
Please provide the full name, credentials, official position(s), and 
relevant affiliations for the speaker and a brief description of the 
intended topic. Presentations that contain material with a commercial 
bias, advertising, marketing, or solicitations will not be allowed. A 
meeting summary will be available on the NBSB website post-meeting.

FOR FURTHER INFORMATION CONTACT: CAPT Christopher Perdue; NBSB 
Designated Federal Official, (202) 480-7226; [email protected].

Dawn O'Connell,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2023-23532 Filed 10-24-23; 8:45 am]
BILLING CODE 4150-37-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.